A Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions (Dexpanthenol)
2026年6月12日 更新者:Wooshin Labottach Co., Ltd.
A Randomized, Single-Blind, Intra-Individual Controlled Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions
Clinical evaluation of a Dexpanthenol-medicated wound plaster on standardized superficial skin abrasions
研究概览
详细说明
By utilizing a standardized abrasion model (based on the Wigger-Alberti methodology), the study aims to quantify the superior clinical performance of the Plaster compared to a standard plaster (conventional dry) and dry healing (no plaster).
This evidence is crucial to demonstrate that the presence of Dexpanthenol provides a significant clinical benefit in terms of healing speed and aesthetic quality of the repaired tissue.
研究类型
介入性
注册 (估计的)
40
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Adolfo Gasparetto, MD
- 电话号码:+39 3356641965
- 邮箱:adolfogasparetto@nextrasearch.it
研究联系人备份
- 姓名:Alessandro Guzzo, MD
- 电话号码:+39 0429715610
- 邮箱:alessandro.guzzo@aulss6.veneto.it
学习地点
-
-
PD
-
Monselice、PD、意大利、35043
- la U.O.C. Anestesia Rianimazione degli Ospedali Riuniti Padova Sud
-
接触:
- Alessandro Guzzo, MD
- 电话号码:+39 0429714111
- 邮箱:alessandro.guzzo@aulss6.veneto.it
-
首席研究员:
- Alessandro Guzzo, MD
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
接受健康志愿者
是的
描述
Inclusion Criteria:
- Healthy male or female volunteers aged 18 to 64 years (inclusive).
- Informed consent form signed voluntarily before any study-related procedure.
- Subjects willing and able to comply with all study protocol requirements, including scheduled visits and home-wear restrictions.
- Intact, healthy skin on both volar forearms (free of tattoos, scars, sunburns, or active skin lesions in the designated test areas).
- Agree to take precautions to prevent pregnancy (applicable only to non-menopausal women), including abstinence, intrauterine devices (IUDs), progestogen implants, combined estrogenic-progestogen contraceptives, the use of condoms;
Exclusion Criteria:
- Known hypersensitivity or allergy to Dexpanthenol, hydrogel components, acrylic adhesives, or any component of the investigational devices.
- History of keloid formation, hypertrophic scarring, or abnormal wound healing.
- Active dermatological conditions (e.g., psoriasis, eczema, atopic dermatitis, active infections) on the upper extremities.
- History of diabetes mellitus, peripheral vascular disease, or arterial/venous microangiopathy.
- Systemic treatment with corticosteroids, immunosuppressive drugs, Anticoagulants, antiplatelet agents or cytostatic agents within 4 weeks prior to Baseline, or anticipated need during the study.
- Topical treatment (steroids, retinoids, antibiotics, or moisturizers) applied to the volar forearms within 2 weeks prior to Baseline.
- Active heavy smokers (more than 10 cigarettes per day) or users of nicotine-replacement therapies (nicotine alters cutaneous microcirculation and significantly impairs wound healing kinetics)
- Pregnant or lactating women, or women of childbearing potential not using highly effective contraception (see inclusion criteria).
- Not willing and able to comply with all study protocol requirements
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:单组作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Dexpanthenol
On the wound will be applied an experimental Hydrogel plaster with Dexpanthenol
|
On the wound will be applied daily an hydrogel plaster with Dexpanthenol
|
|
有源比较器:Standard plaster
On the wound will be applied a standard plaster, with no active ingredients
|
On the wound will be daily applicated a standard plaster on the market
|
|
无干预:No treatment
The wound is not covered or medicated
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Re-epithelialization Rate
大体时间:day 5 day 7 day 15
|
Measured as the percentage of wound closure compared to baseline (T0) with standardized photography
|
day 5 day 7 day 15
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Kinetics of Wound Closure
大体时间:Day 5 day 7
|
Time to 50% re-epithelialization
|
Day 5 day 7
|
|
Subject-Reported Pain
大体时间:day 5 day 7
|
Pain during wear and upon plaster removal assessed via a 100-mm Visual Analogue Scale (VAS)
|
day 5 day 7
|
|
Scar Quality Assessment
大体时间:day 5 day 7 day 15
|
using the Vancouver Scar Scale (VSS) (scoring vascularity, pigmentation, pliability, and height)
|
day 5 day 7 day 15
|
|
general usability
大体时间:Day 1, day 5, day 7
|
Assessment of the plaster adherence to the perilesional skin over the treatment period using a 5-Point Adhesion Score 0 (100%) to 4 (0% fallen)
|
Day 1, day 5, day 7
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of AE
大体时间:from day 1 to day 15 (all the study duration)
|
Safety outcome
|
from day 1 to day 15 (all the study duration)
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Alessandro Guzzo, MD、la U.O.C. Anestesia Rianimazione degli Ospedali Riuniti Padova Sud con indirizzo via Albere, 30 Monselice
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年9月1日
初级完成 (估计的)
2026年10月1日
研究完成 (估计的)
2026年12月1日
研究注册日期
首次提交
2026年6月3日
首先提交符合 QC 标准的
2026年6月8日
首次发布 (实际的)
2026年6月11日
研究记录更新
最后更新发布 (实际的)
2026年6月16日
上次提交的符合 QC 标准的更新
2026年6月12日
最后验证
2026年6月1日
更多信息
与本研究相关的术语
其他研究编号
- MD03/26/WOOSH/DEX
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
是的
IPD 计划说明
When study will be closed and published
IPD 共享支持信息类型
- 研究方案
- 树液
- 分析代码
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.